Biological Aortic Valve Replacement in Young Patients with Bicuspid Aortic Valve: Is It Still a Viable Option?
This article analyzes outcomes from 498 patients under the age of 65 with bicuspid aortic valve (BAV) undergoing aortic valve replacement (AVR) with bioprostheses due to aortic stenosis (AS).